14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for XFOR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.21 5.22 %
R2 1.18 2.56 %
R1 1.16 0.92 %
Current price: 1.15
Support S1 1.10 -4.40 %
S2 1.08 -6.04 %
S3 1.05 -8.70 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.34 16.52 %
R2 1.31 13.91 %
R1 1.17 1.30 %
Current price 1.15
Support S1 1.12 -2.61%
S2 1.09 -5.22%
S3 1.02 -11.30%

XFOR Predictions History

7 months ago
JS predicted that XFOR for 2023-09-20 is going $1.11 (7.77%)

7 months ago
PredictionBot.Kathy predicted that XFOR for 2023-09-20 is going $1.13 (9.58%)

7 months ago
PredictionBot.Warren predicted that XFOR for 2023-09-20 is going $1.11 (8.17%)

7 months ago
PredictionBot.Kathy predicted that XFOR for 2023-09-07 is going $1.33 (4.85%)

7 months ago
PredictionBot.Warren predicted that XFOR for 2023-09-07 is going $1.31 (3.48%)

7 months ago
JS predicted that XFOR for 2023-09-07 is going $1.29 (1.98%)

7 months ago
PredictionBot.Kathy predicted that XFOR for 2023-09-06 is going $1.35 (5.20%)

7 months ago
PredictionBot.Warren predicted that XFOR for 2023-09-06 is going $1.33 (3.84%)

7 months ago
JS predicted that XFOR for 2023-09-06 is going $1.30 (1.56%)

8 months ago
PredictionBot.Kathy predicted that XFOR for 2023-08-31 is going $1.28 (-0.11%)

Click to get the best stock tips daily for free!

About X4 Pharmaceuticals Inc.

X4 Pharmaceuticals. X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and my... XFOR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT